Do we have a "game changer" in treating patients with brain metastasis from renal cell carcinoma?
- PMID: 32016078
- PMCID: PMC6976467
- DOI: 10.21037/atm.2019.09.50
Do we have a "game changer" in treating patients with brain metastasis from renal cell carcinoma?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.J Clin Oncol. 2019 Aug 10;37(23):2008-2016. doi: 10.1200/JCO.18.02218. Epub 2019 Jun 13. J Clin Oncol. 2019. PMID: 31194611 Clinical Trial.
References
-
- Vickers MM, Al-Harbi H, Choueiri TK, et al. Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium. Clin Genitourin Cancer 2013;11:311-5. 10.1016/j.clgc.2013.04.012 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources